Caudill Cortney

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Caudill Cortney's trades of Halozyme Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-10 2026-03-10
PrS Proposed sale
81,775
482.40
US$1,724,016 		81,775 482.40 US$1,724,016
2026-03-10 2026-03-10
S Sale
76,239 -13.3%
81.24
US$4,784,555 		76,239 -13.3% 81.24 US$4,784,555
2026-03-10 2026-03-09
S Sale
51,997 +45.0%
123.33
US$3,510,729 		51,997 +45.0% 123.33 US$3,510,729
2026-03-10 2026-03-09
S Sale
17,900 -52.1%
67.75
US$1,212,743 		17,900 -52.1% 67.75 US$1,212,743
2026-03-09 2026-03-09
PrS Proposed sale
20,000
67.80
US$1,356,062 		20,000 67.80 US$1,356,062
2025-12-19 2025-11-01
S Sale
4,263 -25.1%
65.19
US$277,905 		4,263 -25.1% 65.19 US$277,905